Sugi Predict

Sugi Predict / Compounds / SCHEMBL24870980

SCHEMBL24870980

SCHEMBL24870980

Brc1ccc(S(c2ccc(Br)cc2)(c2ccc(-c3ccccc3)cc2)c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.71
▸ MAPK1 P28482 1/20 0.71
▸ CA2 P00918 3/20 0.50
▸ CA12 O43570 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ NFKB2 Q00653 1/20 0.50
▸ RELA Q04206 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ CA1 P00915 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ MMP2 P08253 6/20 0.44
▸ MMP1 P03956 4/20 0.44
▸ MMP9 P14780 4/20 0.44
▸ MMP13 P45452 4/20 0.44
▸ MMP7 P09237 4/20 0.44
▸ MMP3 P08254 3/20 0.44
▸ NR1H4 Q96RI1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18745677 0.95 ALDH1A1 (0.64) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL25056811 0.90 ALDH1A1 (0.58) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL19850353 0.87 ALDH1A1 (0.53) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL21766545 0.87 ALDH1A1 (0.53) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL23638077 0.85 CA1 (0.54) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL18978153 0.85 CA1 (0.54) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL25374262 0.84 ALDH1A1 (1.00) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL366308 0.84 ALDH1A1 (1.00) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL17277082 0.84 ALDH1A1 (1.00) ALDH1A1MAPK1CA2CA12CA9
SCHEMBL12367607 0.84 ALDH1A1 (1.00) ALDH1A1MAPK1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11877508-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-01-16 — — US disclosed
US-20230200214-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-22 — — US disclosed
WO-2023282511-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2023-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200214-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM ALDH1A1 969/4885MAPK1 3327/4885CA2 3219/4885
US-11877508-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof EMC1, EMC2, EPCAM ALDH1A1 969/4885MAPK1 3327/4885CA2 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.